| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
79,697 |
71,276 |
$9.43M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
23,218 |
18,318 |
$7.99M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
58,479 |
54,532 |
$7.84M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
6,614 |
6,242 |
$2.59M |
| 70450 |
Computed tomography, head or brain; without contrast material |
8,843 |
8,243 |
$2.10M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
18,177 |
16,130 |
$1.96M |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
4,432 |
4,325 |
$1.60M |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
4,242 |
4,022 |
$1.37M |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
3,280 |
3,097 |
$944K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
5,085 |
4,668 |
$862K |
| G0378 |
Hospital observation service, per hour |
16,484 |
7,361 |
$854K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
7,882 |
7,533 |
$812K |
| 59025 |
Fetal non-stress test |
4,801 |
3,552 |
$804K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
11,986 |
4,143 |
$757K |
| H0018 |
Behavioral health; short-term residential (non-hospital residential treatment program), without room and board, per diem |
3,270 |
235 |
$676K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
14,257 |
7,261 |
$675K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
1,762 |
1,706 |
$529K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
6,139 |
4,464 |
$473K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
2,585 |
2,508 |
$417K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
1,195 |
1,155 |
$397K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
1,030 |
1,007 |
$386K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
3,200 |
2,787 |
$381K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
7,239 |
3,189 |
$355K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
5,020 |
1,888 |
$353K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
7,130 |
6,890 |
$341K |
| 71046 |
Radiologic examination, chest; 2 views |
9,793 |
9,327 |
$329K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
2,505 |
1,639 |
$321K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
534 |
518 |
$303K |
| 95806 |
|
430 |
426 |
$286K |
| 93017 |
|
1,507 |
1,460 |
$286K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
4,960 |
1,921 |
$274K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
4,052 |
2,480 |
$247K |
| 93971 |
|
1,728 |
1,623 |
$228K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
7,344 |
7,031 |
$215K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
31,570 |
26,952 |
$212K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
25,756 |
22,723 |
$210K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
1,432 |
1,393 |
$209K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
282 |
271 |
$207K |
| 12001 |
|
1,056 |
1,021 |
$204K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
1,573 |
1,528 |
$185K |
| 93458 |
|
123 |
112 |
$183K |
| 95811 |
|
349 |
340 |
$181K |
| 12011 |
|
875 |
843 |
$179K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
259 |
258 |
$171K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
1,243 |
1,193 |
$165K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
2,634 |
2,478 |
$159K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
6,164 |
5,896 |
$158K |
| 97803 |
|
3,046 |
2,827 |
$157K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
77,136 |
65,126 |
$156K |
| 36415 |
Collection of venous blood by venipuncture |
111,822 |
88,087 |
$152K |
| 93976 |
|
805 |
748 |
$150K |
| 90870 |
|
1,095 |
315 |
$145K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
7,347 |
7,035 |
$134K |
| 80053 |
Comprehensive metabolic panel |
39,545 |
34,799 |
$131K |
| 71045 |
Radiologic examination, chest; single view |
18,473 |
16,800 |
$129K |
| J3490 |
Unclassified drugs |
107,593 |
46,115 |
$129K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
537 |
522 |
$126K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
4,829 |
3,487 |
$123K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
708 |
685 |
$122K |
| 70498 |
|
539 |
515 |
$122K |
| 76830 |
Ultrasound, transvaginal |
1,767 |
1,698 |
$122K |
| 93970 |
|
770 |
734 |
$112K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
25,735 |
18,660 |
$112K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
2,628 |
2,586 |
$108K |
| 87400 |
|
9,663 |
8,234 |
$104K |
| 97165 |
|
2,287 |
2,129 |
$99K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
526 |
510 |
$95K |
| 78431 |
|
151 |
149 |
$93K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
35,636 |
29,597 |
$93K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
3,176 |
3,119 |
$91K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
31,072 |
25,152 |
$90K |
| 87653 |
|
2,348 |
2,315 |
$88K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
4,068 |
3,939 |
$86K |
| 84702 |
|
11,913 |
10,320 |
$85K |
| 84443 |
Thyroid stimulating hormone (TSH) |
9,056 |
8,771 |
$84K |
| 76642 |
|
691 |
649 |
$82K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
3,253 |
1,074 |
$81K |
| 71250 |
|
940 |
903 |
$80K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
7,599 |
5,515 |
$78K |
| 83880 |
|
8,747 |
7,888 |
$75K |
| 10060 |
|
298 |
286 |
$70K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
19,800 |
16,301 |
$69K |
| 76536 |
|
494 |
484 |
$68K |
| 70486 |
|
1,075 |
1,014 |
$68K |
| 97602 |
|
1,345 |
292 |
$67K |
| 73562 |
|
2,740 |
2,369 |
$64K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
18,458 |
16,816 |
$64K |
| 76801 |
|
663 |
591 |
$64K |
| 97161 |
|
2,930 |
2,724 |
$62K |
| 87480 |
|
7,269 |
6,955 |
$62K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
3,376 |
3,212 |
$60K |
| 74022 |
|
1,696 |
1,611 |
$55K |
| 97802 |
|
752 |
726 |
$51K |
| 97535 |
Self-care/home management training, each 15 minutes |
1,936 |
1,053 |
$51K |
| 80081 |
|
2,502 |
2,407 |
$50K |
| 73630 |
|
2,495 |
2,301 |
$50K |
| 80050 |
General health panel |
4,111 |
4,028 |
$49K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
6,286 |
6,119 |
$49K |
| 87660 |
|
7,332 |
7,014 |
$47K |
| 72110 |
|
1,428 |
1,379 |
$47K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
9,221 |
6,824 |
$47K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
487 |
452 |
$46K |
| 87510 |
|
7,264 |
6,950 |
$44K |
| 84439 |
|
3,730 |
3,604 |
$43K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
128 |
128 |
$43K |
| 76770 |
|
279 |
266 |
$42K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
1,223 |
1,081 |
$40K |
| 73030 |
|
1,865 |
1,698 |
$39K |
| 73610 |
|
2,284 |
2,096 |
$39K |
| 73130 |
|
1,933 |
1,787 |
$39K |
| 94660 |
|
264 |
109 |
$37K |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
99,534 |
25,003 |
$37K |
| 80061 |
Lipid panel |
7,019 |
6,876 |
$37K |
| 84484 |
|
16,453 |
13,943 |
$36K |
| 74018 |
|
1,677 |
1,545 |
$35K |
| 81001 |
|
26,279 |
23,877 |
$33K |
| 83874 |
|
6,420 |
5,439 |
$32K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
22,079 |
17,294 |
$31K |
| 93880 |
|
391 |
379 |
$29K |
| 82553 |
|
5,977 |
5,032 |
$29K |
| 73110 |
|
1,417 |
1,327 |
$28K |
| 87430 |
|
4,117 |
3,979 |
$27K |
| 96376 |
|
7,258 |
4,892 |
$27K |
| 86850 |
|
2,431 |
2,270 |
$27K |
| 77080 |
|
554 |
546 |
$25K |
| 0352U |
|
811 |
785 |
$25K |
| 87077 |
|
6,532 |
6,131 |
$25K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
17,221 |
14,591 |
$25K |
| 97162 |
|
846 |
808 |
$24K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
11,938 |
9,086 |
$24K |
| 0240U |
|
187 |
187 |
$24K |
| 83690 |
|
16,197 |
14,483 |
$24K |
| 12002 |
|
94 |
91 |
$24K |
| 93922 |
|
520 |
507 |
$23K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
7,943 |
7,259 |
$23K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
10,768 |
8,578 |
$23K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
203 |
196 |
$23K |
| 99220 |
|
150 |
132 |
$22K |
| 76376 |
|
203 |
194 |
$21K |
| 82550 |
|
7,696 |
6,343 |
$20K |
| 84144 |
|
1,418 |
1,043 |
$20K |
| 93226 |
|
366 |
355 |
$20K |
| 93925 |
|
164 |
159 |
$19K |
| 93225 |
|
356 |
346 |
$19K |
| 87420 |
|
2,258 |
2,200 |
$18K |
| 86787 |
|
1,530 |
1,464 |
$18K |
| 84112 |
|
345 |
300 |
$18K |
| 82248 |
|
16,663 |
15,033 |
$18K |
| A9270 |
Non-covered item or service |
15,611 |
3,432 |
$18K |
| M0247 |
Intravenous infusion, sotrovimab, includes infusion and post administration monitoring |
53 |
52 |
$17K |
| 97116 |
|
1,177 |
688 |
$16K |
| 90002 |
|
530 |
199 |
$16K |
| 82607 |
|
1,562 |
1,510 |
$16K |
| 86140 |
|
4,401 |
4,020 |
$16K |
| 73502 |
|
1,050 |
972 |
$16K |
| J2704 |
Injection, propofol, 10 mg |
9,851 |
7,658 |
$16K |
| 41899 |
Unlisted procedure, dentoalveolar structures |
13 |
12 |
$16K |
| 85018 |
|
3,307 |
2,968 |
$16K |
| 87070 |
|
2,535 |
2,369 |
$15K |
| 86803 |
|
1,832 |
1,776 |
$15K |
| 83605 |
|
8,697 |
7,570 |
$15K |
| 84145 |
|
3,732 |
3,333 |
$15K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
1,553 |
1,455 |
$15K |
| 85027 |
|
4,961 |
4,038 |
$15K |
| 82950 |
|
2,613 |
2,580 |
$14K |
| 87186 |
|
4,902 |
4,543 |
$14K |
| 70491 |
|
44 |
41 |
$14K |
| 83735 |
|
8,548 |
6,586 |
$14K |
| 87040 |
|
3,320 |
2,997 |
$13K |
| 86900 |
|
2,437 |
2,092 |
$13K |
| 36600 |
|
1,273 |
1,092 |
$13K |
| 87081 |
|
3,799 |
3,695 |
$13K |
| 85610 |
|
12,066 |
10,410 |
$13K |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
32 |
24 |
$13K |
| 85379 |
|
6,289 |
5,870 |
$12K |
| 87506 |
|
119 |
110 |
$12K |
| 85730 |
|
8,912 |
8,108 |
$12K |
| 82803 |
|
1,935 |
1,679 |
$12K |
| 94726 |
|
179 |
174 |
$12K |
| 76870 |
|
135 |
123 |
$12K |
| 94761 |
|
3,198 |
1,436 |
$12K |
| 82962 |
|
4,567 |
2,245 |
$11K |
| J2785 |
Injection, regadenoson, 0.1 mg |
900 |
861 |
$11K |
| 74170 |
|
73 |
70 |
$11K |
| 81003 |
|
11,107 |
10,350 |
$10K |
| 82728 |
|
1,360 |
1,293 |
$10K |
| 70496 |
|
439 |
418 |
$10K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
613 |
587 |
$10K |
| 82150 |
|
3,627 |
3,382 |
$10K |
| 87486 |
|
585 |
564 |
$10K |
| 73590 |
|
847 |
702 |
$10K |
| J8597 |
Antiemetic drug, oral, not otherwise specified |
5,654 |
5,221 |
$10K |
| Q9957 |
Injection, perflutren lipid microspheres, per ml |
1,298 |
1,224 |
$10K |
| G0379 |
Direct admission of patient for hospital observation care |
155 |
149 |
$10K |
| C8929 |
Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography |
141 |
133 |
$9K |
| 87581 |
|
584 |
563 |
$9K |
| 73080 |
|
619 |
578 |
$9K |
| 99215 |
Prolong outpt/office vis |
577 |
500 |
$9K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,179 |
1,049 |
$9K |
| 94060 |
|
195 |
189 |
$9K |
| 94729 |
|
219 |
213 |
$8K |
| 88307 |
|
186 |
183 |
$8K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
5,662 |
5,189 |
$8K |
| J0500 |
Injection, dicyclomine hcl, up to 20 mg |
835 |
774 |
$8K |
| 82570 |
|
2,087 |
2,023 |
$8K |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
2,411 |
2,229 |
$8K |
| 72131 |
|
195 |
176 |
$7K |
| G0283 |
Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care |
669 |
214 |
$7K |
| 97014 |
|
220 |
76 |
$7K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
2,281 |
1,744 |
$7K |
| J7050 |
Infusion, normal saline solution, 250 cc |
2,767 |
1,744 |
$7K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
2,755 |
2,114 |
$7K |
| 85652 |
|
3,009 |
2,855 |
$7K |
| 72050 |
|
248 |
237 |
$7K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
150 |
135 |
$7K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
336 |
311 |
$6K |
| 99152 |
|
1,334 |
1,217 |
$6K |
| 93312 |
|
25 |
25 |
$6K |
| 78227 |
|
16 |
15 |
$6K |
| J1756 |
Injection, iron sucrose, 1 mg |
95 |
55 |
$6K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
4,167 |
3,288 |
$6K |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
3,645 |
2,772 |
$6K |
| 73090 |
|
576 |
511 |
$6K |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
5,195 |
1,923 |
$6K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
3,973 |
3,220 |
$6K |
| 95819 |
|
24 |
24 |
$6K |
| 72141 |
|
32 |
30 |
$6K |
| 96367 |
|
202 |
173 |
$6K |
| 80076 |
|
976 |
924 |
$6K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
43 |
40 |
$6K |
| J2426 |
Injection, paliperidone palmitate extended release (invega sustenna), 1 mg |
44 |
41 |
$5K |
| 93325 |
|
57 |
55 |
$5K |
| 91010 |
|
12 |
12 |
$5K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
3,101 |
2,185 |
$5K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
2,440 |
2,125 |
$5K |
| 90021 |
|
532 |
453 |
$5K |
| 82565 |
|
1,549 |
1,400 |
$5K |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
2,855 |
2,579 |
$5K |
| 83550 |
|
996 |
946 |
$5K |
| 84146 |
|
603 |
578 |
$5K |
| 90714 |
|
181 |
178 |
$4K |
| J2060 |
Injection, lorazepam, 2 mg |
3,481 |
2,688 |
$4K |
| 80047 |
|
2,435 |
2,277 |
$4K |
| 78492 |
|
12 |
12 |
$4K |
| 84100 |
|
2,621 |
1,888 |
$4K |
| A4649 |
Surgical supply; miscellaneous |
28 |
25 |
$4K |
| 90834 |
Psychotherapy, 45 minutes with patient |
429 |
214 |
$4K |
| 90715 |
|
165 |
164 |
$4K |
| 83540 |
|
1,144 |
1,087 |
$4K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
500 |
491 |
$4K |
| 94760 |
|
1,331 |
1,205 |
$4K |
| 93242 |
|
124 |
122 |
$4K |
| 86901 |
|
3,293 |
3,028 |
$4K |
| 29125 |
|
254 |
241 |
$3K |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
1,242 |
1,045 |
$3K |
| 82043 |
|
1,368 |
1,355 |
$3K |
| J1815 |
Injection, insulin, per 5 units |
3,682 |
1,287 |
$3K |
| S9484 |
Crisis intervention mental health services, per hour |
62 |
36 |
$3K |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
2,840 |
1,593 |
$3K |
| 86592 |
|
345 |
331 |
$3K |
| 86038 |
|
382 |
368 |
$3K |
| 94799 |
|
717 |
655 |
$3K |
| 87075 |
|
1,217 |
1,098 |
$3K |
| J3480 |
Injection, potassium chloride, per 2 meq |
1,349 |
776 |
$3K |
| 73700 |
|
40 |
38 |
$3K |
| 77065 |
Tomosynthesis, mammo |
69 |
66 |
$3K |
| 87205 |
|
1,719 |
1,552 |
$3K |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
272 |
261 |
$3K |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
114 |
99 |
$2K |
| 73552 |
|
369 |
325 |
$2K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
1,300 |
1,046 |
$2K |
| 82746 |
|
421 |
409 |
$2K |
| 84481 |
|
318 |
308 |
$2K |
| 83655 |
|
164 |
159 |
$2K |
| 84153 |
|
284 |
277 |
$2K |
| 84436 |
|
1,053 |
1,002 |
$2K |
| 99153 |
Mod sedat endo service >5yrs |
736 |
663 |
$2K |
| 97166 |
|
90 |
84 |
$2K |
| 73140 |
|
221 |
215 |
$2K |
| 51701 |
|
816 |
710 |
$2K |
| 99205 |
Prolong outpt/office vis |
480 |
403 |
$2K |
| 90791 |
Psychiatric diagnostic evaluation |
27 |
27 |
$2K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
31 |
12 |
$2K |
| 72100 |
|
116 |
108 |
$2K |
| 87149 |
|
21 |
12 |
$2K |
| 90686 |
|
232 |
230 |
$2K |
| 92523 |
|
28 |
27 |
$2K |
| 82784 |
|
213 |
204 |
$2K |
| J2794 |
Injection, risperidone (risperdal consta), 0.5 mg |
50 |
24 |
$2K |
| Q0244 |
Injection, casirivimab and imdevimab, 1200 mg |
16 |
16 |
$2K |
| 82247 |
|
302 |
193 |
$2K |
| 71101 |
|
146 |
141 |
$2K |
| 86780 |
|
171 |
167 |
$2K |
| 84403 |
|
151 |
139 |
$2K |
| 88341 |
|
26 |
24 |
$1K |
| J1644 |
Injection, heparin sodium, per 1000 units |
2,684 |
1,185 |
$1K |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
746 |
680 |
$1K |
| J7510 |
Prednisolone oral, per 5 mg |
1,073 |
956 |
$1K |
| H0001 |
Alcohol and/or drug assessment |
25 |
24 |
$1K |
| 80069 |
|
788 |
479 |
$1K |
| 72072 |
|
97 |
92 |
$1K |
| 99423 |
|
13 |
13 |
$1K |
| 82951 |
|
95 |
94 |
$1K |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
2,513 |
1,843 |
$1K |
| 84156 |
|
580 |
532 |
$1K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
249 |
241 |
$1K |
| 36410 |
|
184 |
155 |
$970.18 |
| 82533 |
|
91 |
77 |
$967.14 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
7,456 |
6,875 |
$944.50 |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
37 |
37 |
$926.79 |
| J3535 |
Drug administered through a metered dose inhaler |
26 |
24 |
$912.37 |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
55 |
53 |
$849.49 |
| 83001 |
|
72 |
69 |
$842.41 |
| 73560 |
|
142 |
119 |
$828.49 |
| 97035 |
|
98 |
24 |
$816.49 |
| 87536 |
|
28 |
28 |
$787.24 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
672 |
647 |
$778.76 |
| 97032 |
|
35 |
13 |
$755.82 |
| 87340 |
|
91 |
89 |
$709.77 |
| S0028 |
Injection, famotidine, 20 mg |
1,000 |
878 |
$662.08 |
| 85014 |
|
522 |
387 |
$625.27 |
| 80164 |
|
144 |
136 |
$624.53 |
| 51702 |
|
39 |
38 |
$583.34 |
| 86376 |
|
62 |
60 |
$560.25 |
| 51798 |
|
514 |
315 |
$539.90 |
| 82952 |
|
97 |
96 |
$514.95 |
| 92610 |
|
13 |
13 |
$471.35 |
| 36430 |
|
28 |
24 |
$437.56 |
| 86308 |
|
197 |
191 |
$436.96 |
| 74019 |
|
13 |
12 |
$429.64 |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
13 |
13 |
$392.47 |
| 83525 |
|
26 |
26 |
$388.24 |
| C9290 |
Injection, bupivacaine liposome, 1 mg |
108 |
107 |
$377.72 |
| 73100 |
|
101 |
79 |
$353.55 |
| 84402 |
|
28 |
25 |
$352.10 |
| 72128 |
|
25 |
25 |
$313.93 |
| 29505 |
|
16 |
14 |
$275.50 |
| 82272 |
|
403 |
380 |
$269.11 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
1,126 |
971 |
$266.51 |
| 86800 |
|
31 |
30 |
$253.87 |
| J1940 |
Injection, furosemide, up to 20 mg |
384 |
231 |
$247.85 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
2,077 |
1,495 |
$247.61 |
| 84132 |
|
472 |
301 |
$246.47 |
| 84550 |
|
79 |
76 |
$237.31 |
| 86923 |
|
44 |
36 |
$205.64 |
| L4350 |
Ankle control orthosis, stirrup style, rigid, includes any type interface (e.g., pneumatic, gel), prefabricated, off-the-shelf |
190 |
185 |
$203.00 |
| 83516 |
|
27 |
25 |
$202.65 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
802 |
415 |
$195.19 |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
428 |
109 |
$190.08 |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
409 |
365 |
$188.20 |
| 82670 |
|
13 |
13 |
$187.42 |
| 73000 |
|
29 |
24 |
$180.89 |
| 84270 |
|
13 |
13 |
$167.57 |
| 72170 |
|
84 |
79 |
$161.30 |
| 73060 |
|
49 |
43 |
$145.68 |
| 84425 |
|
33 |
32 |
$135.67 |
| 88342 |
|
121 |
115 |
$134.74 |
| 0296T |
|
13 |
12 |
$133.23 |
| 81025 |
|
3,304 |
3,127 |
$131.39 |
| 85046 |
|
110 |
76 |
$123.51 |
| 85049 |
|
227 |
208 |
$112.11 |
| J3360 |
Injection, diazepam, up to 5 mg |
412 |
358 |
$109.06 |
| 83615 |
|
202 |
172 |
$107.39 |
| 83002 |
|
14 |
13 |
$100.60 |
| 86431 |
|
20 |
18 |
$94.86 |
| 83921 |
|
14 |
14 |
$92.85 |
| J3411 |
Injection, thiamine hcl, 100 mg |
730 |
567 |
$91.47 |
| 83520 |
|
14 |
14 |
$90.09 |
| J1631 |
Injection, haloperidol decanoate, per 50 mg |
70 |
38 |
$83.59 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
349 |
245 |
$82.90 |
| 87147 |
|
55 |
49 |
$79.92 |
| 82947 |
|
39 |
36 |
$72.70 |
| 85007 |
|
17 |
16 |
$71.60 |
| 88304 |
|
140 |
137 |
$63.32 |
| 82140 |
|
43 |
39 |
$58.28 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
28 |
28 |
$51.33 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
14 |
12 |
$50.00 |
| G0168 |
Wound closure utilizing tissue adhesive(s) only |
33 |
29 |
$47.50 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
368 |
332 |
$46.28 |
| 80320 |
|
405 |
373 |
$43.71 |
| G0008 |
Administration of influenza virus vaccine |
87 |
86 |
$37.51 |
| 87102 |
|
39 |
35 |
$34.01 |
| 80074 |
|
13 |
13 |
$33.06 |
| S4991 |
Nicotine patches, non-legend |
294 |
116 |
$31.02 |
| 87116 |
|
68 |
63 |
$30.67 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
353 |
285 |
$20.98 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
1,338 |
1,211 |
$18.58 |
| J1790 |
Injection, droperidol, up to 5 mg |
792 |
714 |
$18.49 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
910 |
873 |
$17.54 |
| J0295 |
Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm |
197 |
60 |
$12.36 |
| J0735 |
Injection, clonidine hydrochloride, 1 mg |
188 |
177 |
$8.74 |
| 87206 |
|
53 |
50 |
$5.74 |
| 99417 |
Prolong home eval add 15m |
295 |
266 |
$0.00 |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
156 |
150 |
$0.00 |
| C1769 |
Guide wire |
183 |
163 |
$0.00 |
| A9555 |
Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries |
114 |
112 |
$0.00 |
| J7605 |
Arformoterol, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 15 micrograms |
115 |
37 |
$0.00 |
| G8987 |
Self care functional limitation, current status, at therapy episode outset and at reporting intervals |
14 |
13 |
$0.00 |
| C1725 |
Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) |
30 |
28 |
$0.00 |
| 93320 |
|
12 |
12 |
$0.00 |
| 82330 |
|
50 |
37 |
$0.00 |
| J0592 |
Injection, buprenorphine hydrochloride, 0.1 mg |
25 |
12 |
$0.00 |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
18 |
14 |
$0.00 |
| G8988 |
Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
14 |
13 |
$0.00 |
| J7626 |
Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg |
46 |
12 |
$0.00 |
| Q0243 |
Injection, casirivimab and imdevimab, 2400 mg |
26 |
13 |
$0.00 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
163 |
151 |
$0.00 |
| S0077 |
Injection, clindamycin phosphate, 300 mg |
431 |
311 |
$0.00 |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
270 |
247 |
$0.00 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
174 |
160 |
$0.00 |
| 89051 |
|
38 |
26 |
$0.00 |
| 29105 |
|
44 |
41 |
$0.00 |
| 80143 |
|
52 |
51 |
$0.00 |
| A9577 |
Injection, gadobenate dimeglumine (multihance), per ml |
387 |
370 |
$0.00 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
558 |
539 |
$0.00 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
185 |
166 |
$0.00 |
| C1751 |
Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) |
29 |
18 |
$0.00 |
| J1956 |
Injection, levofloxacin, 250 mg |
14 |
12 |
$0.00 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
68 |
58 |
$0.00 |
| 29515 |
|
31 |
30 |
$0.00 |
| 80179 |
|
48 |
48 |
$0.00 |
| 31720 |
|
41 |
38 |
$0.00 |
| J1643 |
Injection, heparin sodium (pfizer), not therapeutically equivalent to j1644, per 1000 units |
26 |
14 |
$0.00 |
| C1729 |
Catheter, drainage |
34 |
25 |
$0.00 |
| L3908 |
Wrist hand orthosis, wrist extension control cock-up, non molded, prefabricated, off-the-shelf |
39 |
38 |
$0.00 |
| L1830 |
Knee orthosis, immobilizer, canvas longitudinal, prefabricated, off-the-shelf |
40 |
37 |
$0.00 |
| 82310 |
|
15 |
15 |
$0.00 |
| J1953 |
Injection, levetiracetam, 10 mg |
39 |
26 |
$0.00 |
| A9537 |
Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries |
16 |
15 |
$0.00 |
| 87207 |
|
20 |
17 |
$0.00 |